Isotonische Natriumchloridlösung Jenapharm (Sodium Chloride)

After intravenous administration, the sodium chloride dissociates into Na+ and Cl‑ ions, which distribute throughout the extracellular fluid space. This raises plasma osmolarity, expands intravascular volume, and restores normal electrolyte concentrations, thereby supporting blood pressure, tissue perfusion, and cellular function.

The prescribed dose is determined by the treating clinician based on the patient’s clinical condition, fluid losses, and electrolyte status. Dosage may be expressed in millilitres per hour or as a total volume to be infused, and it is adjusted according to ongoing monitoring.

Limited specific data are available, but isotonic sodium chloride is generally considered low risk because it contains only physiologic salts. Nevertheless, the decision to use it during pregnancy or lactation should be made by the prescribing physician, weighing potential benefits against any uncertainties.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Isotonische Natriumchloridlösung Jenapharm is comparable to other 0.9 % sodium chloride injection solutions in terms of composition and clinical use. Differences may lie in manufacturing standards, packaging, and regulatory approvals. GNH India ensures that the product meets EU quality specifications and is supplied with full GDP compliance.

The solution should be stored at ambient temperature, preferably below 25 °C, in its original sealed container. Protect it from direct sunlight, excessive heat and moisture. Do not freeze the product, and inspect the vial for any particulate matter or discoloration before use.

The product is administered intravenously, either as a direct infusion or mixed with other intravenous medications. Administration rate and total volume are set by the healthcare professional according to the patient’s fluid needs, with careful monitoring of vital signs and electrolyte levels during the infusion.

Serious risks include fluid overload leading to pulmonary edema, severe hypernatremia that can cause neurological disturbances, and rare allergic reactions such as anaphylaxis. Continuous monitoring of fluid balance, serum electrolytes, and patient response is essential to mitigate these risks.

Patients with known severe hypernatremia, uncontrolled heart failure, or existing fluid overload should avoid this product unless closely supervised. Individuals with a documented hypersensitivity to sodium chloride solutions should also be excluded from treatment.